1. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet 2021; 397(10276): 839–852.
2.
Taylor HS, Adamson GD, Diamond MP, et al. An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis. Int J Gynecol Obstet 2018; 142(2): 131–142.
3.
Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422–469.
4.
Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev 2019; 40(4): 1048–1079.
5.
Chen LC, Hsu JW, Huang KL, et al. Risk of developing major depression and anxiety disorders among women with endometriosis: A longitudinal follow-up study. J Affect Disord 2016; 190: 282–285.
6.
Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science 2005; 308(5728): 1587–1589.
7.
Simoens S, Dunselman G, Dirksen C, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Human Rep 2012; 27(5): 1292–1299.
8.
Rei C, Williams T, Feloney M. Endometriosis in a Man as a Rare Source of Abdominal Pain: A Case Report and Review of the Literature. Case Rep Obstet Gynecol 2018; 2018: 2083121.
9.
Matsuura K, Ohtake H, Katabuchi H, et al. Coelomic metaplasia theory of endometriosis: evidence from in vivo studies and an in vitro experimental model. Gynecol Obstet Invest 1999; 47(Suppl. 1): 18–20.
10.
Dmowski WP, Braun DP. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 2004; 18(2): 245–263.
11.
Koninckx PR, Ussia A, Adamyan L, et al. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertil Steril 2019; 111(2): 327–340.
12.
Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012; 98(3): 511–519.
13.
Kobayashi H, Higashiura Y, Shigetomi H, et al. Pathogenesis of endometriosis: The role of initial infection and subsequent sterile inflammation (Review). Mol Med Rep 2014; 9(1): 9–15.
14.
Khan KN, Fujishita A, Hiraki K, et al. Bacterial contamination hypothesis: a new concept in endometriosis. Reprod Med Biol 2018; 17(2): 125–133.
15.
Dunne EF, Park IU. HPV and HPV-associated diseases. Infect Dis Clin North Am 2013; 27(4): 765–778.
16.
Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338(7): 423–428.
17.
Heidarpour M, Derakhshan M, Derakhshan-Horeh M, et al. Prevalence of high-risk human papillomavirus infection in women with ovarian endometriosis. J Obstet Gynaecol Res 2017; 43(1): 135–139.
18.
Rocha RM, Souza RP, Gimenes F, et al. The high-risk human papillomavirus continuum along the female reproductive tract and its relationship to infertility and endometriosis. Reprod Biomed Online 2019; 38(6): 926–937.
19.
Vestergaard AL, Knudsen UB, Munk T, et al. Low prevalence of DNA viruses in the human endometrium and endometriosis. Arch Virol 2010; 155(5): 695–703.
20.
Oppelt P, Renner SP, Strick R, et al. Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions. Fertil Steril 2010; 93(6): 1778–1786.
21.
Malhotra N, Karmakar D, Tripathi V, et al. Correlation of angiogenic cytokines-leptin and IL-8 in stage, type and presentation of endometriosis. Gynecol Endocrinol 2012; 28(3): 224–227.
22.
Plummer M, Schiffman M, Castle PE, et al. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007; 195(11): 1582–1589.
23.
Hausen H, zur. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92(9): 690–698.
24.
Watanabe A, Taniguchi F, Izawa M, et al. The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis. Hum Reprod 2009; 24(12): 3172–3179.
25.
Bulun SE. Endometriosis. N Engl J Med 2009; 360(3): 268–279.
26.
Melin A, Sparén P, Bergqvist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 2007; 22(11): 3021–3026.
27.
Kim CJ, Um SJ, Kim TY, et al. Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells. Int J Gynecol Cancer 2000; 10(2): 157–164.
28.
Matalliotakis M, Matalliotaki C, Zervou MI, et al. Coexistence of cervical endometriosis with premalignant and malignant gynecological pathologies: report on a series of 27 cases. Women Health 2021; 61(9): 896–901.
29.
Hong YS, Park J, Kim H. Association of endometriosis with genital human papillomavirus infection in US women: a national population-based study. Sci Rep 2023; 13(1): 8020.
30.
Moslehi Z, Derakhshan R, Chaichian S, et al. Correlation of High-Risk Human Papilloma Virus with Deep Endometriosis: A Cross-Sectional Study. Biomed Res Int 2023; 2023: 6793898.
31.
Jamdar F, Farzaneh F, Navidpour F, et al. Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing. Infect Agent Cancer 2018; 13: 6.
32.
Zullo F, Fiano V, Gillio-Tos A, et al. Human papillomavirus infection in women undergoing in-vitro fertilization: effects on embryo development kinetics and live birth rate. Reprod Biol Endocrinol 2023; 21(1): 39.
